NO950757L - Antitussiv - Google Patents

Antitussiv

Info

Publication number
NO950757L
NO950757L NO950757A NO950757A NO950757L NO 950757 L NO950757 L NO 950757L NO 950757 A NO950757 A NO 950757A NO 950757 A NO950757 A NO 950757A NO 950757 L NO950757 L NO 950757L
Authority
NO
Norway
Prior art keywords
antitussives
salts
derivatives
useful
compound
Prior art date
Application number
NO950757A
Other languages
English (en)
Other versions
NO950757D0 (no
Inventor
Hiroshi Nagase
Koji Kawai
Takashi Endoh
Shinya Ueno
Yuji Negishi
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of NO950757D0 publication Critical patent/NO950757D0/no
Publication of NO950757L publication Critical patent/NO950757L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det tilveiebringes nye antitussiver som er forskjellig fra eksisterende antitussiver eller dem som er under utvik- ling. Antitussiver inneholder morfinanderivater representert ved forbindelse 6: OH O Me eller farmakologisk akseptable syreaddisjonssalter derav og disses derivater eller salter som aktive bestanddeler. Antitussivene i henhold til foreliggende oppfinnelse har sterk antitussiv virkning som sterkt selektive K-opioid-ago- nister, og kan således benyttes som nyttige antitussiver.
NO950757A 1993-06-30 1995-02-27 Antitussiv NO950757L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16162693 1993-06-30
PCT/JP1994/001047 WO1995001178A1 (fr) 1993-06-30 1994-06-28 Antitussif

Publications (2)

Publication Number Publication Date
NO950757D0 NO950757D0 (no) 1995-02-27
NO950757L true NO950757L (no) 1995-04-27

Family

ID=15738765

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950757A NO950757L (no) 1993-06-30 1995-02-27 Antitussiv

Country Status (11)

Country Link
US (1) US5739145A (no)
EP (1) EP0657163B1 (no)
KR (1) KR950702833A (no)
CN (1) CN1111900A (no)
AU (1) AU683664B2 (no)
CA (1) CA2143318A1 (no)
DE (1) DE69413933T2 (no)
FI (1) FI950908A (no)
NO (1) NO950757L (no)
TW (1) TW329386B (no)
WO (1) WO1995001178A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ246687A (en) * 1992-01-23 1996-12-20 Toray Industries Morphinan derivative and pharmaceutical compositions thereof
WO1995003307A1 (fr) * 1993-07-19 1995-02-02 Toray Industries, Inc. Agent de protection de cellules cerebrales
AU686203B2 (en) * 1993-07-23 1998-02-05 Toray Industries, Inc. Morphinan derivative and medicinal use
EP0829481A1 (en) * 1996-09-16 1998-03-18 Pfizer Inc. Morphinan hydroxamic acid compounds
US6440987B1 (en) 1996-11-25 2002-08-27 Toray Industries, Inc. Antipruritic
EP1327444B1 (en) 1996-11-25 2005-03-23 Toray Industries, Inc. Antipruritic agent
US6403602B1 (en) * 1997-02-20 2002-06-11 The University Of Kentucky Research Foundation Morphine-6-sulfate analogues and their use for the treatment of pain
DE60039444D1 (de) * 1999-08-24 2008-08-21 Toray Industries Heilmittel für neuropathischen schmerz und versuchstier-modelle des neuropathischen schmerzes
WO2002080918A1 (fr) * 2001-04-02 2002-10-17 Toray Industries, Inc. Agent therapeutique ou prophylactique en cas de miction frequente ou d'incontinence urinaire
WO2006109671A1 (ja) * 2005-04-06 2006-10-19 Toray Industries, Inc. モルヒナン誘導体の結晶及びその製造法
EP2151240B1 (en) 2007-04-24 2013-06-12 Toray Industries, Inc. Therapeutic or prophylactic agent for dyskinesia
ES2555785T3 (es) * 2007-06-22 2016-01-08 Toray Industries, Inc. Remedio o preventivo para esquizofrenia
WO2009103004A1 (en) 2008-02-14 2009-08-20 Alkermes, Inc. Selective opioid compounds
EP2398805A1 (en) * 2009-02-23 2011-12-28 Mallinckrodt LLC (+)-morphinanium quaternary salts and processes for their production
EP2398807A1 (en) * 2009-02-23 2011-12-28 Mallinckrodt LLC (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
JP2012518651A (ja) * 2009-02-23 2012-08-16 マリンクロッド インコーポレイテッド （＋）−モルフィナニウムｎ−オキシドおよびそれらの生成方法
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
US8829020B2 (en) 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
TWI477505B (zh) 2010-01-29 2015-03-21 Toray Industries 膽管疾病之治療或預防劑
KR101960107B1 (ko) * 2010-10-19 2019-03-19 메모리얼 슬로안 케터링 캔서 센터 통증의 치료를 위한 ４,５에이-에폭시모르피난의 ６-아미도 유도체
CN103327977B (zh) 2011-01-31 2016-05-04 东丽株式会社 恶液质的治疗或预防剂
BR112014005421A2 (pt) 2011-09-08 2017-04-04 Mallinckrodt Llc produção de alcaloides sem o isolamento de intermediários
CA3241654A1 (en) 2015-04-30 2016-11-03 Memorial Sloan-Kettering Cancer Center Mitragynine analogs and uses thereof
CN105461727A (zh) * 2015-12-01 2016-04-06 吕涛 一种纳呋拉啡的精制方法
CN106866688B (zh) * 2015-12-10 2019-05-03 山东诚创医药技术开发有限公司 一种纳呋拉啡的精制方法
CN115181109B (zh) * 2021-04-02 2024-06-04 南京正大天晴制药有限公司 吗啡喃衍生物的晶体及其制备方法
CN114736210A (zh) * 2022-03-29 2022-07-12 伊诺药物研究(南京)有限公司 吗啡喃衍生物的一种晶型的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB843908A (en) * 1957-12-20 1960-08-10 Hoffmann La Roche Novel morphinan derivatives and the manufacture thereof
FR1503524A (fr) * 1964-10-17 1967-12-01 Tanabe Seiyaku Co Morphine à noyaux b/c condensés en configuration trans, et son procédé de préparation
US3865943A (en) * 1971-02-19 1975-02-11 Boehringer Sohn Ingelheim Pharmaceutical compositions containing an n-(furyl-methyl)-3-oxy-morphinan and method of use
DE2217420C3 (de) * 1972-04-12 1981-03-12 C.H. Boehringer Sohn, 6507 Ingelheim N-Thienylmethyl-Heterocyclen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
US3880863A (en) * 1973-08-31 1975-04-29 Warner Lambert Co 17-Aralkyl-6 beta-azido-4,5 alpha-epox-ymorphinan-3-01{hu s
US4521601A (en) * 1981-05-20 1985-06-04 The United States Of America As Represented By The Department Of Health & Human Services Practical total synthesis unnatural enantiomers of opium-derived morphinans
US4401672A (en) * 1981-10-13 1983-08-30 Regents Of The University Of Minnesota Non-addictive narcotic antitussive preparation
US4613668A (en) * 1983-12-22 1986-09-23 The United States Of America As Represented By The Department Of Health And Human Services Short total synthesis or morphinan compounds which uses cyclization of a cycloalkylcarbonyl compound selected from cyclopropylcarbonyl and cyclobutylcarbonyl
US4730048A (en) * 1985-12-12 1988-03-08 Regents Of The University Of Minnesota Gut-selective opiates
US4912114A (en) * 1988-03-18 1990-03-27 Sandoz Ltd. Morphinan derivatives
JPH03163030A (ja) * 1989-08-28 1991-07-15 Arizona Technol Dev Corp アヘン剤活性を選択的に強化し、アヘン剤耐性と依存性を軽減するための組成物と方法
NZ246687A (en) * 1992-01-23 1996-12-20 Toray Industries Morphinan derivative and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
CN1111900A (zh) 1995-11-15
US5739145A (en) 1998-04-14
TW329386B (en) 1998-04-11
FI950908A (fi) 1995-04-28
AU683664B2 (en) 1997-11-20
WO1995001178A1 (fr) 1995-01-12
EP0657163A4 (en) 1995-12-13
FI950908A0 (fi) 1995-02-28
KR950702833A (ko) 1995-08-23
AU6984494A (en) 1995-01-24
CA2143318A1 (en) 1995-01-12
EP0657163A1 (en) 1995-06-14
DE69413933D1 (de) 1998-11-19
NO950757D0 (no) 1995-02-27
DE69413933T2 (de) 1999-04-08
EP0657163B1 (en) 1998-10-14

Similar Documents

Publication Publication Date Title
NO950757L (no) Antitussiv
DK0696280T3 (da) Substituerede pyrrolidin-3-yl-alkyl-piperidiner anvendelige som tachykinin-antagonister
NO180538C (no) N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer, farmasöytiske blandinger som inneholder dem og mellomprodukter ved fremstilling av derivatene
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
HK1036931A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients.
ES2175127T3 (es) Derivados de la quinazolina y su uso.
AU1442297A (en) Piperidone tachykinin antagonists
DK0808303T3 (da) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreceptorantagonister
WO1992019211A3 (en) Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
NO20044810L (no) Farmasoytisk formulering med oyeblikkelig frigjoring
IT1283110B1 (it) Composti a scheletro colchicinico,loro uso come farmaci e composizioni che li contengono
ES2180751T3 (es) Inhibidor de metastasis de cancer.
NO995685D0 (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasöytiske blandinger
KR960000225A (ko) 기관지천식 치료제
MXPA04004371A (es) Agente antipruritico.
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
ATE287895T1 (de) Substituierte tetrahydropyranderivate sowie verfahren zu deren herstellung
UY26971A1 (es) Nuevos antagonistas de neuroquinina, procedimiento para su preparación y composiciones farmacéuticas que contienen estos compuestos
EP0700395A1 (en) INDOLA DERIVATIVES AS INHIBITORS OF STEROIDAL 5-g (a) -REDUCTASE
CA2239053A1 (en) Diphenyl pyridyl ethane derivatives as pde iv inhibitors
SE9304065D0 (sv) New compound
NO954801L (no) Fluorfenoksybutyl-piperidinyl-metyl-aminobenzotiazoler som antiarytmiske midler av klasse III
NO303640B1 (no) Ny forbindelse, Leustroducsin H, farmas°ytisk preparat som omfatter den, og dens anvendelse til fremstilling av et slikt preparat
GT199300005A (es) Derivados de ciclohexano y tetrahidropirano